Literature DB >> 3372644

Determination of busulfan in human plasma by gas chromatography with electron-capture detection.

T L Chen1, L B Grochow, L A Hurowitz, R B Brundrett.   

Abstract

A simple and highly sensitive gas chromatographic method has been developed for the determination of busulfan in human plasma. After extraction of plasma specimens (clinical or spiked) with ethyl acetate, busulfan and the internal standard [1,8-bis(methanesulfonyloxy)octane] were derivatized with 2,3,5,6-tetrafluorothiophenol to yield compounds monitored by a 63Ni electron-capture detector. Sample recoveries from extraction and derivatization were greater than 78 and 91%, respectively. The limit of quantitation was 0.01 microgram/ml (0.04 microM) in 1 ml of plasma with a linear relationship over the 0.01-1.0 micrograms/ml (0.04-4 microM) concentration range. The method has been applied to analyze the plasma versus time profile of busulfan in human subjects following administration of an oral dose of 4 mg/kg per day as a marrow ablative chemotherapy for bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3372644     DOI: 10.1016/0378-4347(88)80034-3

Source DB:  PubMed          Journal:  J Chromatogr


  7 in total

Review 1.  The role of busulfan in bone marrow transplantation.

Authors:  M Hassan
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

2.  Gas-chromatographic analysis of busulfan for therapeutic drug monitoring.

Authors:  L Embree; R B Burns; J R Heggie; G L Phillips; D E Reece; J J Spinelli; D O Hartley; N J Hudon; J H Goldie
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Phase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients.

Authors:  Thomas C Shea; Christine Walko; Yunro Chung; Anastasia Ivanova; Julia Sheets; Kamakshi Rao; Don Gabriel; Terry Comeau; William Wood; James Coghill; Paul Armistead; Stefanie Sarantopoulos; Jonathan Serody
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-22       Impact factor: 5.742

4.  Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignancies.

Authors:  R A Larson; R B Geller; L Janisch; J Milton; L B Grochow; M J Ratain
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia.

Authors:  A S Stein; M R O'Donnell; T W Synold; A C Dagis; A Tsirunyan; A P Nademanee; P M Parker; V A Pullarkat; D S Snyder; R T Spielberger; J Y C Wong; J C Alvarnas; S H Thomas; S J Forman
Journal:  Bone Marrow Transplant       Date:  2010-12-13       Impact factor: 5.483

6.  A rapid & sensitive liquid chromatography- tandem mass spectrometry method for the quantitation of busulfan levels in plasma & application for routine therapeutic monitoring in haematopoietic stem cell transplantation.

Authors:  Salamun Desire; Ezhil Pavai Mohanan; Biju George; Vikram Mathews; Mammen Chandy; Alok Srivastava; Poonkuzhali Balasubramanian
Journal:  Indian J Med Res       Date:  2013-04       Impact factor: 2.375

7.  Quantification of human plasma-busulfan concentration by liquid chromatography-tandem mass spectrometry.

Authors:  Soo Young Moon; Min Kyoo Lim; Susie Hong; Yongbum Jeon; Minje Han; Sang Hoon Song; Kyoung Soo Lim; Kyung-Sang Yu; In-Jin Jang; Ji Won Lee; Hyoung Jin Kang; Junghan Song
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.